Bing‐Mae Chen

1.4k citations

25 papers · 1.1k indexed · 1 hit paper · h-index 15

Impact in

Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Immunology top 10%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction

Papers in ⓘ

Molecular Biology 15
- Glycosylation and Glycoproteins Research 5
- Cancer therapeutics and mechanisms 3
- Protein purification and stability 3
Radiology, Nuclear Medicine and Imaging 10
- Monoclonal and Polyclonal Antibodies Research 9
- Radiopharmaceutical Chemistry and Applications 3

Co-authors: Steve R. Roffler (25 shared papers)Tian-Lu Cheng (3 shared papers)Tian‐Lu Cheng (6 shared papers)Ji‐Wang Chern (4 shared papers)Mi‐Hua Tao (1 shared paper)André Lieber (1 shared paper)Pei‐Chun Wu (1 shared paper)Lung‐Sen Kao (1 shared paper)
Journals: Journal of Controlled Release (4 papers)PLoS ONE (3 papers)ACS Nano (2 papers)International Journal of Cancer (2 papers)Analytical Chemistry (1 paper)
Partner nations: Taiwan Israel United States

In The Last Decade

Bing‐Mae Chen

25 papers receiving 1.1k citations

Hit Papers

align trajectories log scale

Polyethylene Glycol Immunogenicity: Theoretical, Clinical, and Practical Aspects of Anti-Polyethylene Glycol Antibodies 2021 · 378 citations

Peers

Countries citing papers authored by Bing‐Mae Chen

Since Specialization

Citations

This map shows the geographic impact of Bing‐Mae Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing‐Mae Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing‐Mae Chen more than expected).

Fields of papers citing papers by Bing‐Mae Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing‐Mae Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing‐Mae Chen. The network helps show where Bing‐Mae Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Bing‐Mae Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bing‐Mae Chen Line = papers co-authored together Bing‐Mae Chen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Polyethylene Glycol Immunogenicity: Theoretical, Clinical, and Practical Aspects of Anti-Polyethylene Glycol Antibodies ACS Nano ·Bing‐Mae Chen, Tian-Lu Cheng, Steve R. Roffler Hit paper breakdown →	2021	378
2	Cutting Edge: Mechanical Forces Acting on T Cells Immobilized via the TCR Complex Can Trigger TCR Signaling The Journal of Immunology ·Ya-Chen Li, Bing‐Mae Chen, Pei‐Chun Wu, Tian‐Lu Cheng, Lung‐Sen Kao, Mi‐Hua Tao, André Lieber, Steve R. Roffler	2010	170
3	Tumor-associated antigen L6 and the invasion of human lung cancer cells. PubMed ·Yu‐Rong Kao, Jin‐Yuan Shih, Wei‐Chun Wen, Ya‐Ping Ko, Bing‐Mae Chen, Yi-Lin Chan, Yi‐Wen Chu, Pan‐Chyr Yang, Cheng‐Wen Wu, Steve R. Roffler	2003	73
4	Efficient Clearance of Poly(ethylene glycol)-Modified Immunoenzyme with Anti-PEG Monoclonal Antibody for Prodrug Cancer Therapy Bioconjugate Chemistry ·Tian‐Lu Cheng, Bing‐Mae Chen, Ji‐Wang Chern, Ming‐Fang Wu, Steve R. Roffler	2000	55
5	Anti-PEG antibodies before and after a first dose of Comirnaty® (mRNA-LNP-based SARS-CoV-2 vaccine) Journal of Controlled Release ·Yaelle Bavli, Bing‐Mae Chen, Guy Gross, Alon Y. Hershko, Keren Turjeman, Steve R. Roffler, Yechezkel Barenholz	2023	53
6	Antibodies against Poly(ethylene glycol) Activate Innate Immune Cells and Induce Hypersensitivity Reactions to PEGylated Nanomedicines ACS Nano ·Wei-An Chen, Deng-Yuan Chang, Bing‐Mae Chen, Yi‐Chen Lin, Y. Barenholz, Steve R. Roffler	2023	52
7	Poly(ethylene glycol) modification of β-glucuronidase-antibody conjugates for solid-tumor therapy by targeted activation of glucuronide prodrugs Cancer Immunology Immunotherapy ·Tian‐Lu Cheng, Bing‐Mae Chen, Lai‐Yee Chan, Pin-Yi Wu, Ji‐Wang Chern, Steve R. Roffler	1997	44
8	Replacement of L-amino acid peptides with D-amino acid peptides mitigates anti-PEG antibody generation against polymer-peptide conjugates in mice Journal of Controlled Release ·Meilyn Sylvestre, Shixian Lv, Lucy F. Yang, Nicholas Luera, David J. Peeler, Bing‐Mae Chen, Steve R. Roffler, Suzie H. Pun	2021	30
9	Entropy-driven binding of gut bacterial β-glucuronidase inhibitors ameliorates irinotecan-induced toxicity Communications Biology ·Hsien‐Ya Lin, Chia-Yu Chen, Ting‐Chien Lin, Lun-Fu Yeh, Wei‐Che Hsieh, Shijay Gao, Pierre‐Alain Burnouf, Bing‐Mae Chen, Tung-Ju Hsieh, P. Dashnyam, Yen-Hsi Kuo, Zhijay Tu, Steve R. Roffler, Chun‐Hung Lin	2021	30
10	Cure of malignant ascites and generation of protective immunity by monoclonal antibody–targeted activation of a glucuronide prodrug in rats International Journal of Cancer ·Bing‐Mae Chen, Lai‐Yee Chan, Shing‐Ming Wang, Ming‐Fang Wu, Ji‐Wang Chern, Steve R. Roffler	1997	25
11	Both IgM and IgG Antibodies against Polyethylene Glycol Can Alter the Biological Activity of Methoxy Polyethylene Glycol-Epoetin Beta in Mice Pharmaceutics ·Tien-Ching Chang, Bing‐Mae Chen, Wen-Wei Lin, Pei‐Hua Yu, Yi‐Wen Chiu, Yuan-Tsong Chen, Jer‐Yuarn Wu, Tian-Lu Cheng, Daw‐Yang Hwang, Steve R. Roffler	2019	23
12	Accelerated clearance by antibodies against methoxy PEG depends on pegylation architecture Journal of Controlled Release ·Yi‐Chen Lin, Bing‐Mae Chen, Trieu Thi My Tran, Tien-Ching Chang, Talal Salem Al‐Qaisi, Steve R. Roffler	2023	20
13	Impact of anti-PEG antibody affinity on accelerated blood clearance of pegylated epoetin beta in mice Biomedicine & Pharmacotherapy ·Tien-Ching Chang, Bing‐Mae Chen, Jer-Yuan Wu, Tian-Lu Cheng, Steve R. Roffler	2021	19
14	Micro-PET Imaging of β-Glucuronidase Activity by the Hydrophobic Conversion of a Glucuronide Probe Radiology ·Shey-Cherng Tzou, Steve R. Roffler, Kuo‐Hsiang Chuang, Hsin-Pei Yeh, Chien-Han Kao, Yu-Cheng Su, C. C. Cheng, Wei‐Lung Tseng, Jentaie Shiea, I-Hong Harm, Kai-Wen Cheng, Bing‐Mae Chen, Jeng‐Jong Hwang, Tian‐Lu Cheng, Hsin‐Ell Wang	2009	15
15	Therapy of human cervical carcinoma with monoclonal antibody-Pseudomonas exotoxin conjugates. PubMed ·Steve R. Roffler, M H Yu, Bing‐Mae Chen, E Tung, M Y Yeh	1991	15
16	Effect of Cellular Location of Human Carboxylesterase 2 on CPT-11 Hydrolysis and Anticancer Activity PLoS ONE ·Yuan-Ting Hsieh, Hsuan-Pei Lin, Bing‐Mae Chen, Ping-Ting Huang, Steve R. Roffler	2015	14
17	Chimeric peptide containing both B and T cells epitope of tumor-associated antigen L6 enhances anti-tumor effects in HLA-A2 transgenic mice Cancer Letters ·Su-I Lin, Ming‐Hsi Huang, Yu‐Wen E. Chang, I‐Hua Chen, Steve R. Roffler, Bing‐Mae Chen, Yuh‐Pyng Sher, Shih‐Jen Liu	2016	12
18	Enhancement Effect of a Variable Topology of a Membrane-Tethered Anti-Poly(ethylene glycol) Antibody on the Sensitivity for Quantifying PEG and PEGylated Molecules Analytical Chemistry ·Wen-Wei Lin, Yi‐An Cheng, Chien-Han Kao, Steve R. Roffler, Yu‐Chi Lee, Bing‐Mae Chen, Yuan-Chin Hsieh, I‐Ju Chen, Bo-Cheng Huang, Yeng‐Tseng Wang, Yi‐Ching Tung, Ming‐Yii Huang, Fang‐Ming Chen, Tian‐Lu Cheng	2017	12
19	The B7-1 Cytoplasmic Tail Enhances Intracellular Transport and Mammalian Cell Surface Display of Chimeric Proteins in the Absence of a Linear ER Export Motif PLoS ONE ·Yi-Chieh Lin, Bing‐Mae Chen, Weicheng Lu, Su Chien-I, Zeljko M. Prijovich, Chung Wen-Chuan, Pei‐Yu Wu, Kai‐Chuan Chen, I-Chiao Lee, Juan Ting-Yi, Steve R. Roffler	2013	9
20	High-Throughput Sorting of the Highest Producing Cell via a Transiently Protein-Anchored System PLoS ONE ·Kuo‐Hsiang Chuang, Yuan-Chin Hsieh, I-Shiuan Chiang, Chih-Hung Chuang, Chien-Han Kao, Ta-Chun Cheng, (unknown), Yeng‐Tseng Wang, Wen-Wei Lin, Bing‐Mae Chen, Steve R. Roffler, Ming-Yii Huang, Tian‐Lu Cheng	2014	8

About Bing‐Mae Chen

Bing‐Mae Chen is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Immunology, Oncology and Hematology, having authored 25 papers that have together received 1.1k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (9 papers), Glycosylation and Glycoproteins Research (5 papers), Cancer therapeutics and mechanisms (3 papers), Cell Adhesion Molecules Research (3 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Protein purification and stability (3 papers), Immunotherapy and Immune Responses (3 papers) and Complement system in diseases (2 papers). The work is most often cited by research in Biomaterials (248 citations), Immunology (270 citations), Pharmaceutical Science (66 citations), Immunology and Allergy (63 citations) and Radiology, Nuclear Medicine and Imaging (183 citations). Bing‐Mae Chen has collaborated with scholars based in Taiwan, Israel and United States. Frequent co-authors include Steve R. Roffler, Tian-Lu Cheng, Tian‐Lu Cheng, Ji‐Wang Chern, Mi‐Hua Tao, André Lieber, Pei‐Chun Wu, Lung‐Sen Kao, Ming‐Fang Wu and Yi‐Chen Lin. Their work appears in journals such as Journal of Controlled Release, PLoS ONE, ACS Nano, International Journal of Cancer and Analytical Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact